BREAKING NEWS
Site Under Development, Content Population and SEO, Soft Launch 1st January 2020
.png)
The Phoenix atherectomy system combines the benefits of existing atherectomy systems to deliver a unique, hybrid atherectomy option to help physicians tailor the treatment approach for each patient. It cuts, captures, and clears diseased tissue with one insertion. Phoenix treats a broad range of tissue types, from soft plaque to calcified arteries, and can be used for lesions above and below the knee.
Front cutter clears tissue in a way that may help reduce potential trauma to the vessel.
Continuous capture and passive clearance of debulked material into the catheter resulted in a <1% rate of symptomatic distal emboli in the EASE trial.
Phoenix is battery-powered and handle-operated. No capital equipment or additional procedural accessories are required.
Low-profile, front-cutting design allows for direct lesion access without having to first pass a nosecone. The over-the-wire design aids in trackability and pushability of catheter.
EASE trial data confirms the ability of Phoenix to effectively treat a broad range of tissue types, from soft plaque to calcified arteries, for lesions both above and below the knee. The 1.8 and 2.2 mm tracking catheters are suitable for treating small vessels or highly stenosed lesions. The 2.4 mm deflecting catheter is suitable for larger vessels or eccentric lesions.
1.8mm x 130cm tracking catheter
1.8mm x 149cm tracking catheter
2.2mm x 130cm tracking catheter
2.2mm x 149cm tracking catheter
2.4mm x 127cm deflecting catheter